Side Effects From Wegovy: What Most People Experience and What Needs Medical Attention

The side effects most people actually notice on Wegovy

Nausea sits at the top of almost every list for a straightforward reason: semaglutide slows gastric emptying, which is part of how it reduces appetite, and that same slowing can leave the stomach feeling unsettled. The NHS medicines page records nausea as very common (affecting more than one in ten people), alongside vomiting, diarrhoea, constipation, stomach pain, bloating, burping and reflux. Headache, fatigue and dizziness also appear in the common category.

None of that is as alarming as it reads in a list. The pattern (and this is worth understanding before you decide whether to start) is that these effects cluster around two moments: the beginning of treatment and the step up to each new dose. Once the body has had a few weeks at a given dose, the intensity typically drops. Smaller, lower-fat meals, eating slowly and staying well hydrated all reduce the day-to-day burden; your prescriber or pharmacist can go into detail.

Injection-site reactions (redness, itching, bruising at the injection spot) are also common and are one reason to rotate injection sites each week. For a fuller comparison of how semaglutide's profile compares across different populations, the broader semaglutide side-effect picture covers that ground.

Side effects that need a medical conversation rather than waiting them out

A question our prescribers hear most weeks is some version of: "How do I know when a side effect is serious?" The honest answer is that most are not, but there is a short list where the right move is to seek help rather than hope it passes.

Pancreatitis is the clearest example. In January 2026 the MHRA issued a Drug Safety Update confirming acute pancreatitis as a known, infrequent but potentially serious risk with GLP-1 medicines. The symptom to act on is severe, persistent pain in the upper abdomen that spreads to the back, sometimes accompanied by vomiting. This is not ordinary nausea. If it happens, stop using the pen and seek urgent medical attention.

Other signs that warrant the same prompt response: symptoms suggesting gallbladder problems (sharp upper-right abdominal pain, fever, jaundice); signs of serious dehydration from prolonged vomiting or diarrhoea (very dark urine, dizziness, inability to keep fluids down); any symptoms of an allergic reaction (swelling of the face, lips or throat, difficulty breathing, rash). Low mood or thoughts of self-harm, although rare, should also prompt a call to a clinician or the NHS 111 service.

The longer-term side-effect profile of Wegovy is a separate question that comes up once people are established on treatment.

Deciding whether the side-effect profile is right for your situation

The decision to start Wegovy, continue through a difficult patch or adjust the dose is genuinely a clinical one. That is not a bureaucratic point; it is a practical one. Two people with identical BMIs and the same comorbidity can have very different tolerances for GI symptoms depending on other medicines they take, their medical history and how weight-related conditions are affecting their lives.

NICE recommends stopping Wegovy if less than five per cent weight loss has been achieved after six months on the maintenance dose, under NICE technology appraisal TA875. That kind of structured review (weighing benefit against side-effect burden) is what a clinical consultation exists for.

At nume, our prescribers discuss side effects as part of every consultation, not as a footnote. Suitability is never assumed. If you want to understand Wegovy's side effects in more depth before you consult, or if you are already on treatment and want to compare notes on what is typical, our aftercare team is available seven days a week. Eligibility and the consultation process are explained on our treatment page; an overview of how Wegovy fits into the weight management landscape is on our Wegovy information page.

A note on reporting and what to do if something feels wrong

If you experience a side effect that concerns you, tell your prescriber. If you want to flag it to the regulator as well, the MHRA Yellow Card scheme accepts reports directly from patients, your report contributes to ongoing safety monitoring for the medicine. You can also use Yellow Card to report a counterfeit or suspect pen.

For people wondering whether any side effects can be avoided entirely, the answer is rarely none at all, though some people do have a much lighter experience. That topic (what drives the variation) is covered on our page about people who report few or no side effects from Wegovy. And if cost is part of what you are weighing up before deciding, our Wegovy pricing page sets out the context honestly. Worth reading before you commit either way.